Bodo Brocks

1.1k total citations
21 papers, 828 citations indexed

About

Bodo Brocks is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Bodo Brocks has authored 21 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Bodo Brocks's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Protein purification and stability (6 papers) and Advanced Biosensing Techniques and Applications (5 papers). Bodo Brocks is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Protein purification and stability (6 papers) and Advanced Biosensing Techniques and Applications (5 papers). Bodo Brocks collaborates with scholars based in Germany, United States and Switzerland. Bodo Brocks's co-authors include Dieter Moosmayer, Klaus Pfizenmaier, Ralf Ostendorp, Manuela Dürr, Stefan Steidl, Christian Frisch, Stefanie Urlinger, Pilar Garin‐Chesa, Yvonne Stark and Bernd Hubner and has published in prestigious journals such as Journal of Molecular Biology, Applied and Environmental Microbiology and Hepatology.

In The Last Decade

Bodo Brocks

21 papers receiving 788 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bodo Brocks 499 428 156 147 135 21 828
Piet J. Boender 330 0.7× 200 0.5× 65 0.4× 87 0.6× 84 0.6× 24 582
Baisong Mei 704 1.4× 128 0.3× 103 0.7× 94 0.6× 135 1.0× 44 1.4k
Sheau-Line Feng 464 0.9× 222 0.5× 185 1.2× 129 0.9× 22 0.2× 9 699
Shigeto Kawai 339 0.7× 145 0.3× 281 1.8× 188 1.3× 20 0.1× 28 837
Martha L. Peterson 1.3k 2.6× 154 0.4× 272 1.7× 84 0.6× 61 0.5× 41 1.6k
Claudio Sustmann 1.1k 2.2× 537 1.3× 262 1.7× 379 2.6× 26 0.2× 18 1.4k
Nadine Tuaillon 378 0.8× 571 1.3× 548 3.5× 277 1.9× 33 0.2× 31 1.2k
Debra L. Wood 401 0.8× 76 0.2× 175 1.1× 244 1.7× 47 0.3× 32 846
Kang Hu 618 1.2× 73 0.2× 216 1.4× 536 3.6× 40 0.3× 27 1.3k
Jan‐Willem Arends 571 1.1× 523 1.2× 146 0.9× 170 1.2× 7 0.1× 9 834

Countries citing papers authored by Bodo Brocks

Since Specialization
Citations

This map shows the geographic impact of Bodo Brocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bodo Brocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bodo Brocks more than expected).

Fields of papers citing papers by Bodo Brocks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bodo Brocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bodo Brocks. The network helps show where Bodo Brocks may publish in the future.

Co-authorship network of co-authors of Bodo Brocks

This figure shows the co-authorship network connecting the top 25 collaborators of Bodo Brocks. A scholar is included among the top collaborators of Bodo Brocks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bodo Brocks. Bodo Brocks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaehrling, Jan, et al.. (2015). Solution Equilibrium Titration for High-Throughput Affinity Estimation of Unpurified Antibodies and Antibody Fragments. SLAS DISCOVERY. 20(10). 1256–1267. 9 indexed citations
2.
Jaehrling, Jan, Sebastian Jäger, Karin Felderer, et al.. (2014). Characterization and screening of IgG binding to the neonatal Fc receptor. mAbs. 6(4). 928–942. 78 indexed citations
3.
Ostendorp, Ralf, et al.. (2013). An automated immunoassay for early specificity profiling of antibodies. mAbs. 5(2). 279–287. 10 indexed citations
4.
Steidl, Stefan, et al.. (2008). In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification. Molecular Immunology. 46(1). 135–144. 75 indexed citations
5.
Rothe, Christine, Stefanie Urlinger, Josef Prassler, et al.. (2008). The Human Combinatorial Antibody Library HuCAL GOLD Combines Diversification of All Six CDRs According to the Natural Immune System with a Novel Display Method for Efficient Selection of High-Affinity Antibodies. Journal of Molecular Biology. 376(4). 1182–1200. 183 indexed citations
6.
Hillig, R.C., Stefanie Urlinger, Jörg Fanghänel, et al.. (2008). Fab MOR03268 Triggers Absorption Shift of a Diagnostic Dye via Packaging in a Solvent-shielded Fab Dimer Interface. Journal of Molecular Biology. 377(1). 206–219. 8 indexed citations
7.
Brocks, Bodo, et al.. (2007). Generation and optimization of human antagonistic antibodies against TIMP-1 as potential therapeutic agents in fibrotic diseases. Human Antibodies. 15(4). 115–124. 10 indexed citations
8.
Ostendorp, Ralf, et al.. (2005). Characterization of high-affinity antibodies by electrochemiluminescence-based equilibrium titration. Analytical Biochemistry. 339(1). 182–184. 21 indexed citations
9.
Poetz, Oliver, Ralf Ostendorp, Bodo Brocks, et al.. (2005). Protein microarrays for antibody profiling: Specificity and affinity determination on a chip. PROTEOMICS. 5(9). 2402–2411. 63 indexed citations
10.
Parsons, Christopher J., Blair U. Bradford, Clark Q. Pan, et al.. (2004). Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology. 40(5). 1106–1115. 155 indexed citations
11.
Frisch, Christian, Bodo Brocks, Ralf Ostendorp, et al.. (2003). From EST to IHC: human antibody pipeline for target research. Journal of Immunological Methods. 275(1-2). 203–212. 15 indexed citations
12.
Schmidt, Alexej, Jörg F. Rippmann, Bodo Brocks, et al.. (2001). Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas. International Journal of Cancer. 92(2). 240–248. 1 indexed citations
13.
Schmidt, Alexej, Bodo Brocks, Wolfgang J. Rettig, et al.. (2001). Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas. International Journal of Cancer. 92(2). 240–248. 39 indexed citations
14.
15.
Rippmann, Jörg F., Christian Hoischen, Bodo Brocks, et al.. (1998). Procaryotic Expression of Single-Chain Variable-Fragment (scFv) Antibodies: Secretion in L-Form Cells of Proteus mirabilis Leads to Active Product and Overcomes the Limitations of Periplasmic Expression in Escherichia coli. Applied and Environmental Microbiology. 64(12). 4862–4869. 48 indexed citations
16.
17.
Moosmayer, Dieter, Harald Wajant, Elke Gerlach, et al.. (1996). Characterization of Different Soluble TNF Receptor (TNFR80) Derivatives: Positive Influence of the Intracellular Domain on Receptor/Ligand Interaction and TNF Neutralization Capacity. Journal of Interferon & Cytokine Research. 16(6). 471–477. 17 indexed citations
18.
Moosmayer, Dieter, et al.. (1995). A Bivalent Immunoadhesin of the Human Interferon-γ Receptor Is an Effective Inhibitor of IFN-γ Activity. Journal of Interferon & Cytokine Research. 15(12). 1111–1115. 3 indexed citations
19.
Moosmayer, Dieter, et al.. (1995). A single-chain TNF receptor antagonist is an effective inhibitor of TNF mediated cytotoxicity.. PubMed. 2(1). 31–40. 14 indexed citations
20.
Brocks, Bodo. (1966). A Comparison of Flufenamic Acid and Phenylbutazone in Osteoarthritis of the Hip. Lara D. Veeken. VIII(suppl 1). 114–118. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Piet J. Boender Breakdown of academic impact, for papers by Baisong Mei Breakdown of academic impact, for papers by Sheau-Line Feng Breakdown of academic impact, for papers by Shigeto Kawai Breakdown of academic impact, for papers by Martha L. Peterson Breakdown of academic impact, for papers by Claudio Sustmann Breakdown of academic impact, for papers by Nadine Tuaillon Breakdown of academic impact, for papers by Debra L. Wood Breakdown of academic impact, for papers by Kang Hu Breakdown of academic impact, for papers by Jan‐Willem Arends
Rankless by CCL
2026